Imodium and Cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Cortef (hydrocortisone). Common drug interactions include urinary tract infection among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Cortef. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Cortef?

Cortef has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 4,254 Cortef users. Check the latest studies of Cortef.



On Aug, 12, 2026

71 people who take Imodium and Cortef together, and have interactions are studied.

Imodium and Cortef drug interactions.

What are the common drug interactions of Imodium and Cortef, by gender? *:

female:

  1. Urinary tract infection
  2. Decreased appetite
  3. Bone disorder
  4. Electrolyte imbalance
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  6. Upper respiratory tract infection
  7. Vomiting
  8. Acquired porphyria (group of disorders that result in a build up of chemicals called porphyrins in the body)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Asthenia (weakness)
  4. Back pain
  5. Bronchial disorder
  6. Cough
  7. Disease progression
  8. Dysgeusia (disorder of the sense of taste)
  9. Dyspnoea (difficult or laboured respiration)
  10. Gout (uric acid crystals building up in the body)

What are the common drug interactions of Imodium and Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Pneumonia
  2. Sepsis (a severe blood infection that can lead to organ failure and death)

10-19:

n/a

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Fatigue (feeling of tiredness)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Renal failure (kidney dysfunction)

40-49:

  1. Renal cell carcinoma (a kidney cancer)
  2. Abdominal pain upper
  3. Endometrial cancer stage iv
  4. Epistaxis (bleed from the nose)
  5. Injection site induration
  6. Injection site pain
  7. Pain
  8. Body temperature decreased
  9. Heart rate decreased
  10. Blood pressure diastolic decreased

50-59:

  1. Arthralgia (joint pain)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fungal infection
  4. Hypertension (high blood pressure)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Vomiting
  7. Weight decreased
  8. Ageusia (loss of taste functions of the tongue)
  9. Asthenia (weakness)
  10. Back pain

60+:

  1. Pain
  2. Nausea (feeling of having an urge to vomit)
  3. Acquired porphyria (group of disorders that result in a build up of chemicals called porphyrins in the body)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  7. Bacteraemia (presence of bacteria in the blood)
  8. Bone disorder
  9. Bone fragmentation
  10. Breast cancer recurrent

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 13 people, 18.31%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 10 people, 14.08%
  3. Pain: 9 people, 12.68%
  4. Nausea And Vomiting: 8 people, 11.27%
  5. Insomnia (sleeplessness): 8 people, 11.27%
  6. Stress And Anxiety: 6 people, 8.45%
  7. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 7.04%
  8. Malignant Melanoma (skin cancer rises from melancytes): 5 people, 7.04%
  9. Itching: 5 people, 7.04%
  10. Depression: 5 people, 7.04%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and hydrocortisone (the active ingredients of Imodium and Cortef, respectively), and Imodium and Cortef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: